Tech Company Financing Transactions

Immuto Scientific Funding Round

Immuto Scientific, operating out of Madison, secured $8 million from Gravity Fund, Great Oaks Venture Capital and private investors.

Transaction Overview

Company Name
Announced On
9/18/2025
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to advance its internal oncology pipeline toward IND-enabling studies and extend the platform into additional areas such as immunology and inflammation.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Madison, WI Undisclosed
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
We envision a world where disease transforms from an inevitable burden into a conquerable challenge. At Immuto Scientific, we apply rigorous engineering principles to ignite bold, irreverent breakthroughs in medicine--exploiting the rogue architecture of disease, defying convention, and driving a radical shift in treatment with fearless optimism.
Profile
Immuto Scientific LinkedIn Company Profile
Social Media
Immuto Scientific Company Twitter Account
Company News
Immuto Scientific News
Facebook
Immuto Scientific on Facebook
YouTube
Immuto Scientific on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Faraz Choudhury
  Faraz Choudhury LinkedIn Profile  Faraz Choudhury Twitter Account  Faraz Choudhury News  Faraz Choudhury on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/17/2025: Fabrix Security venture capital transaction
Next: 9/18/2025: Vibranium Labs venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary